Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Y. Chen, W. Yao, J. Kang, B. Cai, X. Zhou, Z. Liu, P. Chen, D. Sun, J. Zheng, G. Wang, Y. Feng, Y. Xu (Beijing, Shenyang, Shanghai, Langfang, Baotou, Guangzhou, Wuhan, China)
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Session: COPD: acute exacerbations and others
Session type: Poster Discussion
Number: 1870
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Chen, W. Yao, J. Kang, B. Cai, X. Zhou, Z. Liu, P. Chen, D. Sun, J. Zheng, G. Wang, Y. Feng, Y. Xu (Beijing, Shenyang, Shanghai, Langfang, Baotou, Guangzhou, Wuhan, China). Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey. Eur Respir J 2013; 42: Suppl. 57, 1870
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015
Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
COPD severity analysis according to current evaluation criteria – National survey Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015
COPD prevalence in Argentina: The EPOC.AR study Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing Year: 2016
Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014
Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013
Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013
2011 GOLD categories may identify different copd phenotypes Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015
Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013
Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of COPD Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015
Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016
Agreement of severity stages and exacerbations building the new COPD risk groups Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Heterogeneity of group D in the new GOLD classification of COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
Heterogeneity inside group D COPD patients: About 827 cases Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
The 2006 and 2011 GOLD classifications and five-years mortality in COPD Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013
Heterogeneity in prevalence and underdiagnosis of COPD: Results from BOLD, EPI-SCAN, PLATINO, and PREPOCOL Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013
Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014
GOLD and phenotypes: The new Czech COPD guidelines Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015
Influence of the seasons on exacerbation characteristics in a cohort of COPD patients (EXACO study) Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013
Three year follow-up of distribution and stability of patients with COPD according GOLD 2014 Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015